A routine warfarin dose adjustment inside the stability period does not reset the clock at Manulife, GMS or TuGo, provided it was made on INR results to keep the level in range and the condition being treated is otherwise unchanged. Switching from warfarin to a DOAC, starting any blood thinner, or changing an antiplatelet is a change at every insurer. For the other five insurers we compare, no carve-out could be verified in October 2026; confirm at quote time.
The blood thinner is never the condition. It is the treatment for atrial fibrillation, a past clot, a mechanical valve or a stroke, and the insurer tests that condition. The carve-out only stops a routine INR adjustment from counting as a change.
What does each wording say about blood thinners?
Manulife says a routine dose adjustment based only on blood levels is not a change “if you are taking Coumadin (warfarin) or insulin” and the condition is otherwise unchanged. GMS excludes from its definition of alteration a Coumadin or warfarin adjustment that keeps the INR within range under physician direction. TuGo excludes routine dosage adjustments for blood thinner medication within prescribed parameters with blood levels checked regularly, and a temporary stoppage of up to 24 hours for a procedure.
| Insurer (underwriter) | Warfarin adjustment carve-out | DOAC dose change | 24-hour stoppage for a procedure |
|---|---|---|---|
| Manulife CoverMe Plan B (Manufacturers Life) | Yes, based only on blood levels | Not named; a change | Not named; a change |
| 21st Century Enhanced (Manulife) | Not verified; confirm at quote time | Not verified | Not verified |
| GMS (Group Medical Services) | Yes, to keep INR in range | Not named; a change | Not named |
| TuGo (iA Financial Group) | Yes, “blood thinner medication” generally | Arguably within the wording; confirm | Yes, up to 24 hours |
| Secure Travel/RIMI (iA Financial Group; claims by MSH) | Not verified; confirm at quote time | Not verified | Not verified |
| Destination (Zurich, Canadian Branch) | Not verified; confirm at quote time | Not verified | Not verified |
| Allianz (CUMIS General Insurance) | Treatment plan must be unchanged in type and frequency | Same | Same |
| Travelance Premier (Old Republic) | Not verified; confirm at quote time | Not verified | Not verified |
Wordings seen October 2026 — the policy document at purchase governs. 21st Century is underwritten by Manulife but has its own wording, which we could not verify on this point.
What counts as a routine adjustment, and what does not?
A routine adjustment is a change in warfarin dose made because an INR result was out of range, with the underlying condition unchanged and no new symptom or event. Anything that changes the drug, adds a drug, or follows a bleed or clot is outside the carve-out.
| Event in the stability period | Inside the carve-out at Manulife, GMS, TuGo? |
|---|---|
| Warfarin dose changed on an INR result, same condition | Yes |
| INR checked, no change | Yes, and not a change anywhere |
| Warfarin switched to apixaban, rivaroxaban or another DOAC | No |
| Blood thinner started for the first time | No |
| Antiplatelet such as clopidogrel added, stopped or changed | No |
| Blood thinner stopped for up to 24 hours for a procedure | TuGo yes; elsewhere confirm |
| Blood thinner stopped for longer, or after a bleed | No, and the bleed is a new event |
| Dose changed after a new clot or stroke | No, the event is a new condition |
The adjustment must stand alone. A warfarin change made because of a bleed, a fall, a new drug interaction or a hospital visit fails the stability test on the event, whatever the carve-out says about the dose.
What should you document?
Get the anticoagulation clinic record or INR log showing each result and dose with dates, the doctor’s written statement of the target INR range and that each adjustment in the stability period was routine, the prescription list with the date each drug started or last changed, and the letter for the condition being treated. If a procedure required a stoppage, record the stop and restart dates.
Keep the completed questionnaire; the THIA Bill of Rights entitles the buyer to a copy before the policy starts. The condition pages explain the rest: atrial fibrillation and stroke and TIA.
What typically voids a claim?
The common pattern is a warfarin-to-DOAC switch declared as no change, because the family saw it as the same treatment. The records show a new prescription, the carve-out does not apply, and the insurer argues misrepresentation. Manulife exclusion 7 denies benefits where the application was not truthful; GMS General Condition 8 denies related claims for non-disclosure.
Any misrepresentation can void the whole policy. TuGo adds a $15,000 deductible to any claim where a questionnaire answer at 60 or over was inaccurate. GMS also declines, at 55 and over, a parent with blood clots or gastrointestinal bleeding diagnosed or newly treated in the last 12 months.
Which insurer suits a parent whose blood thinner changed?
For a routine warfarin adjustment, Manulife, GMS and TuGo cover the condition without waiting, within their periods for everything else. For a switch to a DOAC or a new blood thinner, Secure Travel’s 90 days to 69 is the shortest wait, and TuGo’s 7-day rider to 79 covers the condition sooner for a premium. Travelance counts blood clots toward its two-condition screen.
Is a no-pre-existing plan safer?
No. A no-pre-existing plan excludes the condition the blood thinner treats and every bleed, clot or stroke the adjuster links to it. A plan whose wording exempts routine warfarin adjustments covers the condition from day one.
The parent’s doctor and the insurer’s policy wording decide whether the condition is stable; this page describes insurer rules, not medical advice. SuperVisaDirect’s advisor can run the questionnaire with the parent on the line by callback, Monday to Friday, 8:00am to 6:00pm ET. The same logic applies to insulin; see insulin changes.
Questions people ask
My father's warfarin dose was changed after an INR test. Is he stable?
At Manulife, GMS and TuGo, yes, if the change was a routine adjustment to keep the INR in range and the condition being treated did not change. Their wordings name warfarin or blood thinners as an exception to the change-in-medication rule. At the other insurers, treat it as a change unless confirmed otherwise in writing.
Does switching from warfarin to apixaban count as a change?
Yes, everywhere. A switch between drugs is a new medication, not a dose adjustment, and the carve-outs cover dosage only. The clock restarts on the switch date. The condition the blood thinner treats, usually atrial fibrillation or a past clot, is unstable until the period has run.
What if the blood thinner was stopped for a procedure?
TuGo's wording allows a temporary stoppage of up to 24 hours if required for surgery or a procedure. A longer stoppage is a change at TuGo and at every other insurer, and the procedure is itself a new treatment with its own clock. Record the stop and restart dates.
Do DOACs need the same carve-out?
DOACs are usually fixed-dose, so routine adjustment rarely arises. A DOAC dose reduced because of kidney function or age is a change at most insurers; GMS's carve-out covers warfarin, and TuGo's covers blood thinner medication generally. Ask the insurer in writing before relying on it for a DOAC.
Is a bleed on a blood thinner covered?
A bleed is an emergency and is covered if the condition the blood thinner treats was declared and stable. If the blood thinner was started or switched inside the stability period, the insurer can exclude the bleed as arising from an unstable condition. GMS declines a parent with gastrointestinal bleeding newly treated in the last 12 months at 55 and over.
Get the policy IRCC requires, in minutes
Three questions, one price, one button. The certificate your parent needs is emailed the same day.